Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Gene therapy prospects for Duchenne muscular dystrophy.

Clemens PR, Caskey CT.

Eur Neurol. 1994;34(4):181-5. Review.

PMID:
8082675
2.

X-linked dystrophies: from gene localization to gene therapy.

Chamberlain JS.

Curr Opin Neurol Neurosurg. 1992 Oct;5(5):610-4. Review.

PMID:
1392134
3.

Dystrophin and muscular dystrophy: past, present, and future.

O'Brien KF, Kunkel LM.

Mol Genet Metab. 2001 Sep-Oct;74(1-2):75-88. Review.

PMID:
11592805
4.

Gene therapy for muscular dystrophies: current status and future prospects.

Takeda S, Miyagoe-Suzuki Y.

BioDrugs. 2001;15(10):635-44. Review.

PMID:
11604045
5.

[Molecular therapy of muscular dystrophy].

Takeda S.

Rinsho Shinkeigaku. 2000 Dec;40(12):1267-9. Review. Japanese.

PMID:
11464475
6.

Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.

Zhou GQ, Xie HQ, Zhang SZ, Yang ZM.

Chin Med J (Engl). 2006 Aug 20;119(16):1381-91. Review.

PMID:
16934185
7.

Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy.

Matsuo M.

Brain Dev. 1996 May-Jun;18(3):167-72. Review.

PMID:
8836495
8.

Oligonucleotide-mediated gene therapy for muscular dystrophies.

Rando TA.

Neuromuscul Disord. 2002 Oct;12 Suppl 1:S55-60. Review.

PMID:
12206797
9.

Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?

Wells DJ, Wells KE.

Neuromuscul Disord. 2002 Oct;12 Suppl 1:S11-22. Review.

PMID:
12206790
10.

Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy.

Miranda AF, Francke U, Bonilla E, Martucci G, Schmidt B, Salviati G, Rubin M.

Am J Med Genet. 1989 Feb;32(2):268-73.

PMID:
2648829
11.

Gene therapy in Duchenne muscular dystrophy.

Inui K, Okada S, Dickson G.

Brain Dev. 1996 Sep-Oct;18(5):357-61. Review.

PMID:
8891229
12.

Progress towards gene therapy for Duchenne muscular dystrophy.

Hauser MA, Chamberlain JS.

J Endocrinol. 1996 Jun;149(3):373-8. No abstract available.

PMID:
8691095
13.

Challenges in Duchenne muscular dystrophy.

Davies KE.

Neuromuscul Disord. 1997 Dec;7(8):482-6. Review.

PMID:
9447604
14.

Human dystrophin gene transfer: genetic correction of dystrophin deficiency.

Dickson G, Dunckley M.

Mol Cell Biol Hum Dis Ser. 1993;3:283-302. Review. No abstract available.

PMID:
8111543
15.

Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy.

Quan F, Janas J, Toth-Fejel S, Johnson DB, Wolford JK, Popovich BW.

Am J Hum Genet. 1997 Jan;60(1):160-5.

16.
17.

Problems and potential for gene therapy in Duchenne muscular dystrophy.

Kakulas BA.

Neuromuscul Disord. 1997 Jul;7(5):319-24.

PMID:
9267845
18.

Gene therapy for muscular dystrophy - a review of promising progress.

Gregorevic P, Chamberlain JS.

Expert Opin Biol Ther. 2003 Aug;3(5):803-14. Review.

PMID:
12880380
19.

Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.

Araki E, Nakamura K, Nakao K, Kameya S, Kobayashi O, Nonaka I, Kobayashi T, Katsuki M.

Biochem Biophys Res Commun. 1997 Sep 18;238(2):492-7.

PMID:
9299538
20.

Supplemental Content

Support Center